FindTrial
Sign In

Use of ultrasound for pulmonary evaluation in patients with COVID-19

Pulmonary ultrasound as a tool for assessing patients with COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8gmm6ph
Enrollment
Unknown
Registered
2021-06-07
Start date
2021-01-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Acute Respiratory Syndrome

Interventions

Experimental group: 50 patients with the use of ultrasound to assess the pulmonary condition in patients with severe respiratory condition resulting from COVID infection Control group: 50 patients wit
29304

Sponsors

Instituto Dr José Frota
Lead Sponsor
Instituto Dr José Frota
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: intensive care patients; over 18 years old; of both sexes; diagnosed with COVID-19; use of mechanical ventilation

Exclusion criteria

Exclusion criteria: Age less than 18 years; without diagnosis of COVID-19; without the use of mechanical ventilation

Design outcomes

Primary

MeasureTime frame
worsening evaluation of the acute respiratory condition assessed by pulmonary ultrasound examination.—

Secondary

MeasureTime frame
Quantify the length of stay of patients evaluated on mechanical ventilation. ;Observe the number of deaths found based on pulmonary ultrasound severity patterns.;Correlate the length of hospital stay with the patterns of pulmonary ultrasound findings.—

Countries

Brazil

Contacts

Public ContactDanielle Dumaresq
danidumaresq@terra.com.br+5585999871608

Outcome results

None listed

Source: REBEC (via WHO ICTRP)